
[ Fri, Mar 18th 2022 ]: WOPRAI
[ Fri, Mar 18th 2022 ]: WOPRAI
[ Fri, Mar 18th 2022 ]: WOPRAI
[ Fri, Mar 18th 2022 ]: WOPRAI
[ Fri, Mar 18th 2022 ]: WOPRAI

[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI
[ Thu, Mar 17th 2022 ]: WOPRAI

[ Wed, Mar 16th 2022 ]: WOPRAI
[ Wed, Mar 16th 2022 ]: WOPRAI
[ Wed, Mar 16th 2022 ]: WOPRAI
[ Wed, Mar 16th 2022 ]: WOPRAI
William Plovanic Maintained (TMDX) at Strong Buy with Increased Target to $39 on, Mar 17th, 2022


🞛 This publication is a summary or evaluation of another publication
William Plovanic of Canaccord Genuity, Maintained "TransMedics Group, Inc." (TMDX) at Strong Buy with Increased Target from $38 to $39 on, Mar 17th, 2022.
William has made no other calls on TMDX in the last 4 months.
There is 1 other peer that has a rating on TMDX. Out of the 1 peers that are also analyzing TMDX, all agrees with William's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- David Lewis of "Morgan Stanley" Maintained at Hold with Decreased Target to $15 on, Friday, February 25th, 2022